TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Acacia Pharma Group plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Cosmo Pharmaceuticals N.V.
City and country of registered office (if applicable) Riverside 2, Sir John Rogerson’s Quay, Dublin 2, Ireland
4. Full name of shareholder(s) (if different from 3.)v
Name Cosmo Technologies Ltd.
City and country of registered office (if applicable) Riverside 2, Sir John Rogerson’s Quay, Dublin 2, Ireland
5. Date on which the threshold was crossed or reachedvi: 04/06/2020
6. Date on which issuer notified (DD/MM/YYYY): 05/06/2020
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments
(total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached 18.53% - 18.53% 67,855,918
Position of previous notification (if
applicable) 14.08% - 14.08% 67,855,918
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares
ISIN code (if possible) Number of voting rightsix % of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1) Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Ordinary Shares
GB00BYWF9Y76 12,576,329 - 18.53% -
SUBTOTAL 8. A 12,576,329 18.53%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration
datex Exercise/
Conversion Periodxi Number of voting rights that may be acquired if the instrument is
exercised/converted. % of voting rights
SUBTOTAL 8. B 1